These aren't the highest payouts in the industry, but they have the best chance to steadily climb.
News & Analysis: Eli Lilly and Company
GLP-1 drugs keep getting easier to take.
AbbVie and Eli Lilly have both stumbled this year. Which of these top pharma stocks is better positioned for a rebound?
Two presentations at the World Conference on Lung Cancer will make a big difference for at least four different drugmakers.
It’s rejected a pair of drugs in the last six months.
These three diabetes-oriented companies should be on your radar right now.
Which stock wins in this big-pharma matchup?
Income stocks don't get more consistent than this.
These industry giants could make big moves after this year's World Conference on Lung Cancer.
LLY earnings call for the period ending June 30, 2019.